Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Biaoyang Lin

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
International Journal of Oncology|December 5, 2006
ERG upregulation and related ETS transcription factors in prostate cancerKari Rostad, Monica Mannelqvist, Ole Johan Halvorsen, et al.
Oncotarget|March 5, 2015
Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagyIlya V Ulasov, Nameeta Shah, Natalya V Kaverina, et al.
Plos One|May 10, 2013
p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell modelJan Roger Olsen, Anne Margrete Oyan, Kari Rostad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrenceBiaoyang Lin, Angelita G Utleg, Karsten Gravdal, et al.
Cancer Research|April 19, 2005
Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to diseaseBiaoyang Lin, James T White, Wei Lu, et al.
Plos One|March 6, 2009
Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesisXi-Song Ke, Yi Qu, Kari Rostad, et al.
Plos One|September 3, 2010
The United States of America and scientific researchGregory J Hather, Winston Haynes, Roger Higdon, et al.
Translational Cancer Research|February 4, 2022
Exome sequencing identified six copy number variations as a prediction model for recurrence of primary prostate cancers with distinctive prognosisJie Liu, Jiajun Yan, Ruifang Mao, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|September 26, 2013
Expression Profiling and Proteomic Analysis of JIN Chinese Herbal Formula in Lung Carcinoma H460 XenograftsLuyu Zheng, Weiyi Zhang, Miao Jiang, et al.
Omics : a Journal of Integrative Biology|June 14, 2019
Whole Exome Sequencing Identifies Putative Predictors of Recurrent Prostate Cancer with High AccuracyJie Liu, Ruifang Mao, Guoping Ren, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
International Journal of Oncology|December 5, 2006
ERG upregulation and related ETS transcription factors in prostate cancerKari Rostad, Monica Mannelqvist, Ole Johan Halvorsen, et al.
Oncotarget|March 5, 2015
Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagyIlya V Ulasov, Nameeta Shah, Natalya V Kaverina, et al.
Plos One|May 10, 2013
p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell modelJan Roger Olsen, Anne Margrete Oyan, Kari Rostad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrenceBiaoyang Lin, Angelita G Utleg, Karsten Gravdal, et al.
Cancer Research|April 19, 2005
Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to diseaseBiaoyang Lin, James T White, Wei Lu, et al.
Plos One|March 6, 2009
Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesisXi-Song Ke, Yi Qu, Kari Rostad, et al.
Plos One|September 3, 2010
The United States of America and scientific researchGregory J Hather, Winston Haynes, Roger Higdon, et al.
Translational Cancer Research|February 4, 2022
Exome sequencing identified six copy number variations as a prediction model for recurrence of primary prostate cancers with distinctive prognosisJie Liu, Jiajun Yan, Ruifang Mao, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|September 26, 2013
Expression Profiling and Proteomic Analysis of JIN Chinese Herbal Formula in Lung Carcinoma H460 XenograftsLuyu Zheng, Weiyi Zhang, Miao Jiang, et al.
Omics : a Journal of Integrative Biology|June 14, 2019
Whole Exome Sequencing Identifies Putative Predictors of Recurrent Prostate Cancer with High AccuracyJie Liu, Ruifang Mao, Guoping Ren, et al.
Pageof 11